TRACON Pharma Stock (NASDAQ: TCON) stock price, news, charts, stock research, profile.
Open | $1.770 |
Close | $1.810 |
Volume / Avg. | 206.653K / 233.963K |
Day Range | 1.700 - 1.880 |
52 Wk Range | 1.590 - 24.000 |
Market Cap | $4.118M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 33.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TRACON Pharma (NASDAQ: TCON) through any online brokerage.
Other companies in TRACON Pharma’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
The latest price target for TRACON Pharma (NASDAQ: TCON) was reported by HC Wainwright & Co. on Wednesday, April 3, 2024. The analyst firm set a price target for 3.00 expecting TCON to rise to within 12 months (a possible 65.75% upside). 7 analyst firms have reported ratings in the last year.
The stock price for TRACON Pharma (NASDAQ: TCON) is $1.81 last updated April 26, 2024 at 5:59 PM EDT.
There are no upcoming dividends for TRACON Pharma.
TRACON Pharma’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for TRACON Pharma.
TRACON Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.